Team Linear takes on the 2026 MACA Cancer 200

Seven years, 200 kilometres and one reason to keep riding Team Linear returned to the MACA Cancer 200 – Ride for the Perkins, continuing a seven-year commitment to supporting cancer research in Western Australia. After 200 kilometres from Perth to Mandurah and back, four Team Linear riders crossed the finish line of the 2026 MACA […]

Our impact that drives us

When the world was impacted by the global pandemic in 2020, Linear made a strategic decision to “adapt and not endure” and sought opportunities to bring its expertise to help tackle the threat. Linear secured the phase I trial for Clover’s protein based vaccine, one of the very first vaccines discovered. Linear accommodated a high […]

Advancing Treatment for RareCholesterol Disorders – HomozygousFamilial Hypercholesterolemia (HoFH)

Homozygous familial hypercholesterolemia (HoFH) is a rare inherited condition where both copies of the gene responsible for clearing “bad” cholesterol (LDL) are faulty or missing. This leads to severe atherosclerosis and premature cardiovascular disease, with untreated patients often experiencing heart attacks and other heart problems before age 20. Because these patients have little or no […]